Sign in
Taking peopleNo phase

Probiotics to help prevent gestational diabetes in pregnant women at high risk

Tests probiotics against placebo in pregnant women at high risk of gestational diabetes.

Key facts

Who runs it
Women's Hospital School Of Medicine Zhejiang University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Preventive Effect of Probiotics in GDM
Status
Recruiting
People taking part
334 people, planned
Started
27 Oct 2023
Planned end
1 Nov 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Probiotics
  • Placebo
Record updated
27 April 2025

Who can take part

The trial is looking for pregnant women at high risk of diabetes in pregnancy (gestational diabetes). They will take probiotic powder or a placebo (dummy powder) each day.

Age
18 Years to 50 Years
Sex
Women only
Disease stage
Pregnant between 12-16 gestational weeks. You must have at least one high-risk sign: pre-pregnancy BMI ≥ 24 kg/m^2, family history of diabetes (type 1 or 2), past gestational diabetes or PCOS (polycystic ovary syndrome), a past very large baby (macrosomia) or stillbirth, or sugar in the urine.
Earlier treatment
You cannot have taken probiotics or prebiotics within the past month.
Main reasons for not taking part
  • Type 1 or type 2 diabetes diagnosed before pregnancy
  • Allergy to the study product parts or similar products
  • Long-term smoking or drinking habits
  • Serious disease of the heart, liver, kidney or digestive system
  • Pregnant with more than one baby

This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnant women who meet the high-risk indicators for GDM and agree to participate in this study.

Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • Pregnant women who meet the high-risk indicators for GDM and agree to participate in this study; included between 12-16 gestational weeks; A woman was considered high risk when her pre-pregnancy BMI ≥ 24 kg/m\^2, having family history of diabetes (type 1 or 2), GDM or PCOS (polycystic ovary syndrome) history, history of delivering macrosomia or stillbirth, or glucose in urine (+)

Who cannot take part

  • Have a history of allergies to the drug components or similar drugs in this study
  • Type 1 or type 2 diabetes patients with definite diagnosis before pregnancy
  • Diseases in other important organs such as heart, liver, and kidney
  • with clear digestive system diseases
  • Taking probiotics or prebiotics within the past month
  • Having long-term smoking or drinking habits
  • Multiple pregnancy
  • with mental or cognitive impairments who are unable to complete this study

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Sex
  • Gestational diabetes mellitus

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Gut microbiota is instrumental in the microbial and metabolic network of pregnant women, and is potentially related with gestational diabetes. Perinatal probiotic intervention contributes to improved glucose regulation during pregnancy. Our randomized, double-centered, placebo-controlled study is planned to recruit 334 pregnant women who is in high risk for gestational diabetes. They will be assumed randomly probiotic powder per day or placebo from 12-16th gestational weeks until Oral Glucose Tolerance Test (OGTT) at 24-28th gestational weeks. Perinatal outcomes about neonatal weight will be registered.

The 2 groups in the trial

  • ProbioticsExisting treatment, for comparison

    Probiotic powder 1 bag per day, as well as health guidance about diet and exercise. From recruitment until OGTT.

  • PlaceboPlacebo, for comparison

    Placebo 1 bag per day. Similar health guidance about diet and exercise. From recruitment until OGTT

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Preventive Effect of Probiotics in Pregnant Women With High-risk for Gestational Diabetes
Plain-language title
Probiotics to help prevent gestational diabetes in pregnant women at high riskGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06938464, who can take part
Record updated
27 April 2025